These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1699 related articles for article (PubMed ID: 25680274)

  • 1. Binding of the Fap2 protein of Fusobacterium nucleatum to human inhibitory receptor TIGIT protects tumors from immune cell attack.
    Gur C; Ibrahim Y; Isaacson B; Yamin R; Abed J; Gamliel M; Enk J; Bar-On Y; Stanietsky-Kaynan N; Coppenhagen-Glazer S; Shussman N; Almogy G; Cuapio A; Hofer E; Mevorach D; Tabib A; Ortenberg R; Markel G; Miklić K; Jonjic S; Brennan CA; Garrett WS; Bachrach G; Mandelboim O
    Immunity; 2015 Feb; 42(2):344-355. PubMed ID: 25680274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An oral commensal associates with disease: chicken, egg, or red herring?
    Colucci F
    Immunity; 2015 Feb; 42(2):208-210. PubMed ID: 25692696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fap2 Mediates Fusobacterium nucleatum Colorectal Adenocarcinoma Enrichment by Binding to Tumor-Expressed Gal-GalNAc.
    Abed J; Emgård JE; Zamir G; Faroja M; Almogy G; Grenov A; Sol A; Naor R; Pikarsky E; Atlan KA; Mellul A; Chaushu S; Manson AL; Earl AM; Ou N; Brennan CA; Garrett WS; Bachrach G
    Cell Host Microbe; 2016 Aug; 20(2):215-25. PubMed ID: 27512904
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Gur C; Maalouf N; Shhadeh A; Berhani O; Singer BB; Bachrach G; Mandelboim O
    Oncoimmunology; 2019; 8(6):e1581531. PubMed ID: 31069151
    [No Abstract]   [Full Text] [Related]  

  • 5. Immunogenicity of a Fap2 peptide mimotope of
    Guevarra LA; Afable ACF; Belza PJO; Dy KJS; Lee SJQ; Sy-Ortin TT; Albano PMSP
    Infect Agent Cancer; 2018; 13():11. PubMed ID: 29619076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of Fusobacterium nucleatum with immunity and molecular alterations in colorectal cancer.
    Nosho K; Sukawa Y; Adachi Y; Ito M; Mitsuhashi K; Kurihara H; Kanno S; Yamamoto I; Ishigami K; Igarashi H; Maruyama R; Imai K; Yamamoto H; Shinomura Y
    World J Gastroenterol; 2016 Jan; 22(2):557-66. PubMed ID: 26811607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor Targeting by
    Abed J; Maalouf N; Parhi L; Chaushu S; Mandelboim O; Bachrach G
    Front Cell Infect Microbiol; 2017; 7():295. PubMed ID: 28713780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fusobacterium nucleatum Increases Proliferation of Colorectal Cancer Cells and Tumor Development in Mice by Activating Toll-Like Receptor 4 Signaling to Nuclear Factor-κB, and Up-regulating Expression of MicroRNA-21.
    Yang Y; Weng W; Peng J; Hong L; Yang L; Toiyama Y; Gao R; Liu M; Yin M; Pan C; Li H; Guo B; Zhu Q; Wei Q; Moyer MP; Wang P; Cai S; Goel A; Qin H; Ma Y
    Gastroenterology; 2017 Mar; 152(4):851-866.e24. PubMed ID: 27876571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fusobacterium nucleatum and T Cells in Colorectal Carcinoma.
    Mima K; Sukawa Y; Nishihara R; Qian ZR; Yamauchi M; Inamura K; Kim SA; Masuda A; Nowak JA; Nosho K; Kostic AD; Giannakis M; Watanabe H; Bullman S; Milner DA; Harris CC; Giovannucci E; Garraway LA; Freeman GJ; Dranoff G; Chan AT; Garrett WS; Huttenhower C; Fuchs CS; Ogino S
    JAMA Oncol; 2015 Aug; 1(5):653-61. PubMed ID: 26181352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Breast cancer colonization by Fusobacterium nucleatum accelerates tumor growth and metastatic progression.
    Parhi L; Alon-Maimon T; Sol A; Nejman D; Shhadeh A; Fainsod-Levi T; Yajuk O; Isaacson B; Abed J; Maalouf N; Nissan A; Sandbank J; Yehuda-Shnaidman E; Ponath F; Vogel J; Mandelboim O; Granot Z; Straussman R; Bachrach G
    Nat Commun; 2020 Jun; 11(1):3259. PubMed ID: 32591509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Direct recognition of Fusobacterium nucleatum by the NK cell natural cytotoxicity receptor NKp46 aggravates periodontal disease.
    Chaushu S; Wilensky A; Gur C; Shapira L; Elboim M; Halftek G; Polak D; Achdout H; Bachrach G; Mandelboim O
    PLoS Pathog; 2012; 8(3):e1002601. PubMed ID: 22457623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T-cell immunoglobulin and ITIM domain, as a potential immune checkpoint target for immunotherapy of colorectal cancer.
    Fathi M; Pustokhina I; Kuznetsov SV; Khayrullin M; Hojjat-Farsangi M; Karpisheh V; Jalili A; Jadidi-Niaragh F
    IUBMB Life; 2021 May; 73(5):726-738. PubMed ID: 33686787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative Proteomic Analysis of Outer Membrane Vesicles from Fusobacterium nucleatum Cultivated in the Mimic Cancer Environment.
    Zhang X; Wang Y; Fan R; Zhang L; Li Z; Zhang Y; Zheng W; Wang L; Liu B; Quan C
    Microbiol Spectr; 2023 Aug; 11(4):e0039423. PubMed ID: 37341631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fusobacterium nucleatum, inflammation, and immunity: the fire within human gut.
    Bashir A; Miskeen AY; Hazari YM; Asrafuzzaman S; Fazili KM
    Tumour Biol; 2016 Mar; 37(3):2805-10. PubMed ID: 26718210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TOX expression decreases with progression of colorectal cancers and is associated with CD4 T-cell density and Fusobacterium nucleatum infection.
    Chen T; Li Q; Zhang X; Long R; Wu Y; Wu J; Fu X
    Hum Pathol; 2018 Sep; 79():93-101. PubMed ID: 29792893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Placental colonization by Fusobacterium nucleatum is mediated by binding of the Fap2 lectin to placentally displayed Gal-GalNAc.
    Parhi L; Abed J; Shhadeh A; Alon-Maimon T; Udi S; Ben-Arye SL; Tam J; Parnas O; Padler-Karavani V; Goldman-Wohl D; Yagel S; Mandelboim O; Bachrach G
    Cell Rep; 2022 Mar; 38(12):110537. PubMed ID: 35320712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fusobacterium nucleatum and colorectal cancer: A mechanistic overview.
    Hashemi Goradel N; Heidarzadeh S; Jahangiri S; Farhood B; Mortezaee K; Khanlarkhani N; Negahdari B
    J Cell Physiol; 2019 Mar; 234(3):2337-2344. PubMed ID: 30191984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The
    Gur C; Maalouf N; Gerhard M; Singer BB; Emgård J; Temper V; Neuman T; Mandelboim O; Bachrach G
    Oncoimmunology; 2019; 8(4):e1553487. PubMed ID: 30906650
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Ye X; Wang R; Bhattacharya R; Boulbes DR; Fan F; Xia L; Adoni H; Ajami NJ; Wong MC; Smith DP; Petrosino JF; Venable S; Qiao W; Baladandayuthapani V; Maru D; Ellis LM
    Cancer Prev Res (Phila); 2017 Jul; 10(7):398-409. PubMed ID: 28483840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blockade of the checkpoint receptor TIGIT prevents NK cell exhaustion and elicits potent anti-tumor immunity.
    Zhang Q; Bi J; Zheng X; Chen Y; Wang H; Wu W; Wang Z; Wu Q; Peng H; Wei H; Sun R; Tian Z
    Nat Immunol; 2018 Jul; 19(7):723-732. PubMed ID: 29915296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 85.